Page 28 - Immunizations News Today

By Colin Kellaher Pfizer has won U.S. Food and Drug Administration expanded approved its Abrysvo respiratory syncytial virus, or RSV, vaccine to include the...

New shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.

The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.

Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.

By Adria Calatayud Valneva said it will receive up to $100 million in additional financing and that it will use the funds to invest in research and...

The world’s second-largest consumer of cocaine bets on a long-shot solution

Back-to-school means back to the doctor. With Missouri schools starting next week, parents are running out of time to get their children’s immunization records up-to-date.

French researchers are targeting tick microbiota so as to indirectly reduce the bacterial load within the vector of Lyme disease.

By Maitane Sardon Valneva said Monday that the U.S. Food and Drug Administration has delayed the target date for completing the regulatory review of the...

By Maitane Sardon Shares in Valneva plunged in early trading Monday after the French biotech company said the U.S. Food and Drug Administration has delayed...